Gore wins Medicare add-on status for Excluder stent graft
W.L. Gore & Assoc. said today that it won new technology status from the U.S. Centers for Medicare & Medicaid Services for its Gore Excluder iliac branch endoprosthesis. Set to go into effect...
View ArticleBoston Scientific to pay $210m for EndoChoice
Boston Scientific (NYSE:BSX) said today that it agreed to pay $210 million for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share offer is slated to...
View ArticleMylan clarifies $104 profit on $600 EpiPens
Mylan (NSDQ:MYL) said again today that it makes just $104 profit on its $600 EpiPen, after the Wall Street Journal reported that the company applied the statutory U.S. tax rate of 37.5% for its...
View ArticleJapanese regulators approve Abiomed’s Impella heart pumps
Abiomed (NSDQ:ABMD) said today that it won approval from the Japanese Ministry of Health, Labor & Welfare’s Pharmaceuticals & Medical Devices Agency for its Impella line of heart pumps. The...
View ArticleElekta touts MR-imaging radiotherapy combo at ASTRO
Richard Hausmann built his career on the physics of imaging – he spent 23 years at Siemens (NYSE:SI) and 4 years at GE (NYSE:GE) developing the magnetic resonance and computerized tomography businesses...
View ArticleIsoRay settles class action shareholders suit for $3.5m
IsoRay (NYSE:ISR) said it inked a $3.5 million settlement deal related to a class action suit brought against it by shareholders in June. The Richland, Wash.-based company is facing putative...
View ArticleMassDevice.com +5 | The top 5 medtech stories for September 27, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleRotation Medical touts new shoulder repair data
Rotation Medical today released data from a study of its bioinductive implants, designed as part of a novel rotator cuff repair system, touting the device’s ability to promote new connective tissue....
View ArticleSentreHeart closes $35m Series D for Lariat trial
SentreHeart said today that it landed a $35 million Series D round from Deerfield Management, with funds slated to support a trial evaluating its Lariat suture delivery system. The Amaze trial aims to...
View ArticleA Wireless Medical Device Manufacturer’s Guide to Market Conformity
In today’s SMART and connected world, medical devices are no exception to the world of wireless technologies. In fact, the number of wireless medical devices is growing exponentially. As medical...
View ArticleXimedica tapped to advise Cambridge MedSpace incubator
Ximedica said today it inked a strategic partnership deal with healthcare technology incubator Cambridge MedSpace. Get the rest of the story at our sister site, Medical Design & Outsourcing The...
View ArticleMedtronic touts 1st-in-human use of Sugar.IQ with Watson ‘cognitive app’
Medtronic (NYSE:MDT) said today it launched its Sugar.IQ with Watson ‘cognitive app’ for people living with diabetes. The 1st users participating in the testing of the final release candidate will...
View ArticleSiemens investors back Kaeser
(Reuters) – Siemens (NYSE:SI) Chief Executive Joe Kaeser has signaled he wants to renew his contract when it runs out in 2018, a move welcomed by investors who have grown to trust the 59-year-old...
View ArticleBreathtec Biomedical taps product developer DTG
Breathtec Biomedical said today it tapped DTG Partners Consultants to aid the company move towards product commercialization. Get the rest of the story at our sister site, Medical Design &...
View ArticlePhenox touts pREset thrombectomy device trial data
German device maker Phenox today released data from a study of its pREset thrombectomy device, touting high rates of positive clinical outcomes and freedom from severe neurological deficits. The...
View ArticleUS issues final rules for clinical trial information reporting
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: A final rule from the US Department of Health and Human Services (HHS) expands clinical trial reporting requirements to the...
View ArticleMedtronic wins FDA nods for TrailBlazer peripheral support cath
Medtronic (NYSE:MDT) said today it won FDA 510(k) clearance for its TrailBlazer angled support catheter designed for use in the peripheral vascular system. The Fridley, Minn.-based company’s newly...
View ArticleAbbott wins FDA nod for Freestyle Libre Pro
Abbott (NYSE:ABT) said today it won FDA premarket approval for the FreeStyle Libre Pro continuous glucose monitoring system designed for use by healthcare professionals to treat patients with diabetes....
View ArticleMediation fails in Abbott’s dispute with Alere over $6B merger
Mediation efforts looking to resolve antitrust disagreements that have stalled the $5.8 billion merger of Alere (NYSE:ALR) and Abbott (NYSE:ABT) have failed, according to an SEC filing from Alere...
View ArticleTitan Medical updates on funding, Sport robotic surgical system dev
Titan Medical (TSE:TMD) yesterday released an update on the progress of its Sport robotic surgical system, saying it has enough funds to support development of “key components” of the system, which has...
View Article